参考文献
(在框内滑动手指即可浏览)
[1] Brown LM,Devesa SS,Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex,stage,and age [J]. J Natl Cancer Inst,2008,100(16): 1184-1187.
[2] Dikken JL,Lemmens VE,Wouters MW,et al. Increased incidence and survival for oesophageal cancer but not for gastric cardia cancer in the Netherlands[J]. Eur J Cancer,2012,48(11): 1624-1632.
[3] Arnold M,Laversanne M,Brown LM,et al. Predicting the future burden of esophageal cancer by histological subtype: International trends in incidence up to 2030[J]. Am J Gastroenterol,2017,112(8): 1247-1255.
[4] Zhou Y,Zhang Z,Zhang Z,et al. A rising trend of gastric cardia cancer in Gansu Province of China[J]. Cancer Lett,2008,269(1): 18-25.
[5] Dubecz A,Solymosi N,Stadlhuber RJ,et al. Does the incidence of adenocarcinoma of the esophagus and gastric cardia continue to rise in the twenty-first century?:a SEER database analysis[J]. J Gastrointest Surg,2014,18(1):124-129.
[6] Kusano C,Gotoda T,Khor CJ,et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan[J]. J Gastroenterol Hepatol,2008,23(11): 1662-1665.
[7] Wang X,Liu FF,Li YM,et al. Comparison on clinicopathological features,treatments and prognosis between proximal gastric cancer and distal gastric cancer: A National Cancer Data Base analysis[J]. J Cancer,2019,10(14): 3145-3153.
[8] Liu K,Yang K,Zhang W,et al. Changes of esophagogastric junctional adenocarcinoma and gastroesophageal reflux disease among surgical patients during 1988-2012: A single-institution,high- volume experience in China[J]. Ann Surg,2016,263(1): 88-95.
[9] Amin M,Edge S,Greene F,et al. AJCC Cancer staging manual [M]. 8th ed. New York: Springer,2017.
[10] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Esophageal and Esophagogastric Junction Cancers (Version 2.2023)[EB/OL]. [2023-04-11]. https://www.nccn.org/professionals/physician_gls/pdf/esophageal.pdf.
[11] National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Gastric cancer (Version 1.2023)[ EB/OL]. (2023-03-10)[2023-05-12]. https://www.nccn.org/professionals/physician_gls/pdf/gastric.pdf.
[12] 日本胃癌学会. 胃癌治療ガイドライン: 医師用[M]. 6版. 東京:金原出版株式会社,2021.
[13] 日本胃癌学会. 胃癌取扱い規約[M]. 15 版. 東京:金原出版株式会社,2017.
[14] Japan Esophageal S. Japanese classification of esophageal cancer,11th edition: part Ⅰ[J]. Esophagus-Tokyo,2017,14 (1): 1-36.
[15] Japan Esophageal S. Japanese classification of esophageal cancer,11th edition: part Ⅱ and Ⅲ. [J]. Esophagus-Tokyo,2017,14 (1): 37-65.
[16] 日本食道学会. 食道癌取扱い規約[M]. 12版. 東京:金原出版株式会社,2022.
[17] 国际食管疾病学会中国分会食管胃结合部疾病跨界联盟,中国医师协会内镜医师分会腹腔镜外科专业委员会,中国医师协会外科医师分会上消化道外科医师专业委员会,等. 食管胃结合部腺癌外科治疗中国专家共识(2018 年版)[J]. 中华胃肠外科杂志,2018,21(9): 961-975.
[18] 中华医学会外科学分会腹腔镜与内镜外科学组. SiewertⅡ型食管胃结合部腺癌腔镜手术治疗中国专家共识(2019版)[J]. 中国实用外科杂志,2019,39(11):1129-1135.
[19] Bosman FT,Carneiro F,Hruban RH,et al. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Digestive System[M]. 4th ed. Lyon:IARC Press,2010.
[20] Siewert JR,Holscher AH,Becker K,et al. Cardia cancer: attempt at a therapeutically relevant classification[J]. Chirurg,1987,58(1): 25-32.
[21] Siewert JR,Stein HJ. Carcinoma of the gastroesophageal junction - classification,pathology and extent of resection[J]. Dis Esophagus,1996,9(3): 173-182.
[22] Nishi M,Kajisa T,Akune T,et al. Cardia cancer proposal of cancer in the esophagogastric junction[J]. Geka Shinryo,1973,15: 1328-1338.
[23] Sugano K,Spechler S,El-Omar E,et al. Kyoto international consensus report on anatomy,pathophysiology and clinical significance of the gastro-oesophageal junction[J]. Gut,2022,71(8):1488-1514.
[24] Kumamoto T,Kurahashi Y,Niwa H,et al. True esophagogastric junction adenocarcinoma: background of its definition and current surgical trends[J]. Surg Today,2020,50(8):809-814.
[25] Yoshikawa T. Esophagogastric junction cancer in the TNM classification[J]. Nihon Geka Gakkai Zasshi,2015,116(1): 35-39.
[26] Hasegawa S,Yoshikawa T,Aoyama T,et al. Esophagus or stomach? The seventh TNM classification for Siewert type Ⅱ/Ⅲ junctional adenocarcinoma[J]. Ann Surg Oncol,2013,20(3): 773-779.
[27] Gertler R,Stein HJ,Loos M,et al. How to classify adenocarcinomas of the esophagogastric junction: As esophageal or gastric cancer?[J]. Am J Surg Pathol,2011,35(10): 1512-1522.
[28] Suh YS,Han DS,Kong SH,et al. Should adenocarcinoma of the esophagogastric junction be classified as esophageal cancer? A comparative analysis according to the seventh AJCC TNM classification [J]. Ann Surg,2012,255(5): 908-915.
[29] Sano T,Coit DG,Kim HH,et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project[J]. Gastric Cancer,2017,20(2): 217-225.
[30] Chan DS,Reid TD,Howell I,et al. Systematic review and metaanalysis of the influence of circumferential resection margin involvement on survival in patients with operable oesophageal cancer[J]. Br J Surg,2013,100(4): 456-464.
[31] Wu J,Chen QX,Teng LS,et al. Prognostic significance of positive circumferential resection margin in esophageal cancer: A systematic review and Meta-analysis[J]. Ann Thorac Surg,2014,97(2): 446-453.
[32] Bickenbach KA,Gonen M,Strong V,et al. Association of positive transection margins with gastric cancer survival and local recurrence[J]. Ann Surg Oncol,2013,20(8): 2663-2668.
[33] Bissolati M,Desio M,Rosa F,et al. Risk factor analysis for involvement of resection margins in gastric and esophagogastric junction cancer:An Italian multicenter study[J]. Gastric Cancer,2017,20(1): 70-82.
[34] Ito H,Clancy TE,Osteen RT,et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach?[J]. J Am Coll Surg,2004,199(6): 880-886.
[35] Mariette C,Castel B,Balon JM,et al. Extent of oesophageal resection for adenocarcinoma of the oesophagogastric junction [J]. Eur J Surg Oncol,2003,29(7): 588-593.
[36] Koterazawa Y,Ohashi M,Hayami M,et al. Required esophageal resection length beyond the tumor boundary to ensure a negative proximal margin for gastric cancer with gross esophageal invasion or esophagogastric junction cancer[J]. Gastric Cancer,2023,26(3):451-459.
[37] Barbour AP,Rizk NP,Gonen M,et al. Adenocarcinoma of the gastroesophageal junction: influence of esophageal resection margin and operative approach on outcome[J]. Ann Surg,2007,246(1): 1-8.
[38] Mine S,Sano T,Hiki N,et al. Proximal margin length with transhiatal gastrectomy for Siewert type Ⅱ and Ⅲ adenocarcinomas of the oesophagogastric junction[J]. Br J Surg,2013,100(8):1050-1054.
[39] Shen JG,Cheong JH,Hyung WJ,et al. Intraoperative frozen section margin evaluation in gastric cancer of the cardia surgery [J]. Hepatogastroenterology,2006,53(72): 976-978.
[40] Furukawa H,Hiratsuka M,Imaoka S,et al. Limited surgery for early gastric cancer in cardia[J]. Ann Surg Oncol,1998,5(4): 338-341.
[41] Pu YW,Gong W,Wu YY,et al. Proximal gastrectomy versus total gastrectomy for proximal gastric carcinoma. A Meta-analysis on postoperative complications,5-year survival,and recurrence rate[J]. Saudi Med J,2013,34(12): 1223-1228.
[42] Wen L,Chen XZ,Wu B,et al. Total vs. proximal gastrectomy for proximal gastric cancer: a systematic review and meta-analysis [J]. Hepatogastroenterology,2012,59(114): 633-640.
[43] Mariette C,Piessen G,Briez N,et al. Oesophagogastric junction adenocarcinoma: which therapeutic approach?[J]. Lancet Oncol,2011,12(3): 296-305.
[44] 中华医学会外科学分会腹腔镜与内镜外科学组,中国研究型医院学会机器人与腹腔镜外科专业委员会,中国抗癌协会腔镜与机器人外科分会,等. 腹腔镜胃癌手术操作指南(2023版)[J]. 中国实用外科杂志,2023,43(4):361-370.
[45] Casson AG,Darnton SJ,Subramanian S,et al. What is the optimal distal resection margin for esophageal carcinoma?[J]. Ann Thorac Surg,2000,69(1): 205-209.
[46] 国家卫生健康委员会. 胃癌诊疗规范(2018 年版)[J]. 肿瘤综合治疗电子杂志,2019,5(1): 55-82.
[47] Kurokawa Y,Hiki N,Yoshikawa T,et al. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction[J]. Surgery,2015,157(3): 551-555.
[48] Koyanagi K,Kato F,Kanamori J,et al. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type Ⅱ adenocarcinoma: A retrospective single-institution study[J]. Ann Gastroenterol Surg,2018,2(3): 187-196.
[49] Yamashita H,Seto Y,Sano T,et al. Results of a nation- wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma[J]. Gastric Cancer,2017,20(suppl 1): 69-83.
[50] Kurokawa Y,Takeuchi H,Doki Y,et al. Mapping of lymph node metastasis from esophagogastric junction tumors: A prospective nationwide multicenter study[J]. Ann Surg,2021,274(1):120-127.
[51] Hosokawa Y,Kinoshita T,Konishi M,et al. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan[J]. Ann Surg Oncol,2012,19(2): 677-683.
[52] Kakeji Y,Yamamoto M,Ito S,et al. Lymph node metastasis from cancer of the esophagogastric junction,and determination of the appropriate nodal dissection[J]. Surg Today,2012,42(4): 351-358.
[53] Lewis I. The surgical treatment of carcinoma of the oesophagus;with special reference to a new operation for growths of the middle third[J]. Br J Surg,1946,34: 18-31.
[54] Nguyen NT,Follette DM,Lemoine PH,et al. Minimally invasive Ivor Lewis esophagectomy[J]. Ann Thorac Surg,2001,72(2): 593-596.
[55] Feith M,Stein HJ,Siewert JR. Adenocarcinoma of the esophagogastric junction: surgical therapy based on 1602 consecutive resected patients[J]. Surg Oncol Clin N Am,2006,15(4): 751-764.
[56] Matsuda T,Kurokawa Y,Yoshikawa T,et al. Clinicopathological characteristics and prognostic factors of patients with Siewert type Ⅱ esophagogastric junction carcinoma: A retrospective multicenter study[J]. World J Surg,2016,40(7): 1672-1679.
[57] Kurokawa. Final analysis results in a Japanese nationwide prospective study of esophagogastirc junction cancer[R]. Yokohama:International Gastirc Cancer Congress(IGCC2023),14 June 2023.
[58] Yamashita H,Katai H,Morita S,et al. Optimal extent of lymph node dissection for Siewert type Ⅱ esophagogastric junction carcinoma[J]. Ann Surg,2011,254(2): 274-780.
[59] de Boer AG,Van Lanschot JJ,Van Sandick JW,et al. Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus[J]. J Clin Oncol,2004,22(20): 4202-4208.
[60] Hulscher JB,Van Sandick JW,de Boer AG,et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus[J]. N Engl J Med,2002,347(21): 1662-1669.
[61] Omloo JM,Lagarde SM,Hulscher JB,et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the mid/distal esophagus: five-year survival of a randomized clinical trial[J]. Ann Surg,2007,246(6): 992-1000.
[62] Sasako M,Sano T,Yamamoto S,et al. Left thoracoabdominal approach versus abdominal- transhiatal approach for gastric cancer of the cardia or subcardia: A randomised controlled trial [J]. Lancet Oncol,2006,7(8): 644-651.
[63] Kurokawa Y,Sasako M,Sano T,et al. Ten-year follow-up results of a randomized clinical trial comparing left thoracoabdominal and abdominal transhiatal approaches to total gastrectomy for adenocarcinoma of the oesophagogastric junction or gastric cardia[J]. Br J Surg,2015,102(4): 341-348.
[64] Sugita S,Kinoshita T,Kaito A,et al. Short-term outcomes after laparoscopic versus open transhiatal resection of Siewert type Ⅱ adenocarcinoma of the esophagogastric junction[J]. Surg Endosc,2018,32(1): 383-390.
[65] Mariette C,Markar SR,Dabakuyo-Yonli TS,et al. Hybrid minimally invasive esophagectomy for esophageal cancer[J]. N Engl J Med,2019,380(2): 152-162.
[66] 王大广,李伟,张洋,等. 经食管裂孔下纵隔淋巴结清扫在SiewertⅡ型食管胃结合部腺癌根治术中应用价值研究[J]. 中国实用外科杂志,2022,42(2):187-192.